ARTV
Price
$10.93
Change
-$0.21 (-1.89%)
Updated
Aug 21 closing price
Capitalization
534.37M
4 days until earnings call
Intraday BUY SELL Signals
RADX
Price
$2.44
Change
+$0.15 (+6.55%)
Updated
Aug 21 closing price
Capitalization
16.84M
32 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ARTV vs RADX

ARTV vs RADX Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ARTV vs. RADX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARTV is a Hold and RADX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 23, 2026
Stock price -- (ARTV: $10.93 vs. RADX: $2.44)
Brand notoriety: ARTV and RADX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARTV: 36% vs. RADX: 67%
Market capitalization -- ARTV: $534.37M vs. RADX: $16.84M
ARTV [@Biotechnology] is valued at $534.37M. RADX’s [@Biotechnology] market capitalization is $16.84M. The market cap for tickers in the [@Biotechnology] industry ranges from $138.91B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARTV’s FA Score shows that 1 FA rating(s) are green whileRADX’s FA Score has 1 green FA rating(s).

  • ARTV’s FA Score: 1 green, 4 red.
  • RADX’s FA Score: 1 green, 4 red.
According to our system of comparison, ARTV is a better buy in the long-term than RADX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARTV’s TA Score shows that 3 TA indicator(s) are bullish while RADX’s TA Score has 4 bullish TA indicator(s).

  • ARTV’s TA Score: 3 bullish, 5 bearish.
  • RADX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, RADX is a better buy in the short-term than ARTV.

Price Growth

ARTV (@Biotechnology) experienced а -4.54% price change this week, while RADX (@Biotechnology) price change was -4.69% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.69%. For the same industry, the average monthly price growth was +15.94%, and the average quarterly price growth was +3349.70%.

Reported Earning Dates

ARTV is expected to report earnings on Aug 27, 2026.

RADX is expected to report earnings on Sep 24, 2026.

Industries' Descriptions

@Biotechnology (+3.69% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARTV($534M) has a higher market cap than RADX($16.8M). ARTV YTD gains are higher at: 154.779 vs. RADX (-53.257). RADX has higher annual earnings (EBITDA): -42.33M vs. ARTV (-89.43M). ARTV has more cash in the bank: 86.8M vs. RADX (36.4M). RADX has higher revenues than ARTV: RADX (1.68M) vs ARTV (0).
ARTVRADXARTV / RADX
Capitalization534M16.8M3,179%
EBITDA-89.43M-42.33M211%
Gain YTD154.779-53.257-291%
P/E RatioN/AN/A-
Revenue01.68M-
Total Cash86.8M36.4M238%
Total Debt10.3MN/A-
TECHNICAL ANALYSIS
Technical Analysis
ARTVRADX
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
80%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
80%
Momentum
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
85%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
88%
Advances
ODDS (%)
Bullish Trend 19 days ago
89%
Bullish Trend 13 days ago
81%
Declines
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
89%
Bullish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
88%
Bearish Trend 3 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
ARTV
Daily Signal:
Gain/Loss:
RADX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PEPG3.140.10
+3.46%
PepGen
TPST1.040.02
+1.96%
Tempest Therapeutics Inc
APD305.104.77
+1.59%
Air Products & Chemicals
AVTX19.830.01
+0.05%
Avalo Therapeutics
CE46.80-0.18
-0.38%
Celanese Corp

ARTV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARTV has been loosely correlated with RANI. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if ARTV jumps, then RANI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARTV
1D Price
Change %
ARTV100%
-1.89%
RANI - ARTV
47%
Loosely correlated
+3.41%
RADX - ARTV
44%
Loosely correlated
+6.55%
CELC - ARTV
34%
Loosely correlated
+3.27%
IRON - ARTV
33%
Loosely correlated
+1.23%
AURA - ARTV
32%
Poorly correlated
+0.39%
More

RADX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RADX has been loosely correlated with PCSA. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if RADX jumps, then PCSA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RADX
1D Price
Change %
RADX100%
+6.55%
PCSA - RADX
47%
Loosely correlated
-3.03%
ARTV - RADX
44%
Loosely correlated
-1.89%
VTGN - RADX
33%
Poorly correlated
+1.20%
CVKD - RADX
31%
Poorly correlated
+1.26%
FBIOP - RADX
29%
Poorly correlated
-0.60%
More